Ketotifen Eye prep
Eye drops contains benzalkonium chloride as a preservative, which may be deposited in soft contact lenses; thereforeKetotifen eye drops should not be instilled while the patient is wearing contact lenses. The lenses should be removed before application of the drops and not reinserted earlier than 15 minutes after use. Lactation: Not known if distributed in milk; use caution
Allergic conjunctivitis
Patients with known hypersensitivity to ketotifen or to any of the excipients of the preparation.
N/A
Generally side effects of Ketotifen are localized ocular toxicity and hypersensitivity such as burning or stinging, punctate corneal epithelial erosion, dry eyes, eyelid disorder, photophobia, keratitis, lacrimation etc. Systemic side effects are very rare, there may be headache, urticaria, dry mouth and allergic reaction.
Ketotifen selectively and noncompetitively inhibits the release of mediators from cells involved in hypersensitivity reactions. It is also a mast cell stabiliser.
Reduced platelet count with oral antidiabetics. Potentially Fatal: May potentiate CNS effects of sedatives, hypnotics, antihistamines and alcohol.
Pregnancy Category: C Lactation: Not known if distributed in milk; use caution
Ophthalmic Allergic conjunctivitis Adult: As 0.025% solution: Instill 1 drop into the affected eye(s) bid.
Ophthalmic Allergic conjunctivitis Adult: As 0.025% solution: Instill 1 drop into the affected eye(s) bid. Child: >3 yr: As 0.025% solution: Instill 1 drop into the affected eye(s) bid.
N/A
N/A
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.